Impact of intensification with raltegravir on HIV-1-infected individuals receiving monotherapy with boosted PIs.
Puertas MC, Gómez-Mora E, Santos JR, Moltó J, Urrea V, Morón-López S, Hernández-Rodríguez A, Marfil S, Martínez-Bonet M, Matas L, Muñoz-Fernández MA, Clotet B, Blanco J, Martinez-Picado J.
Puertas MC, et al. Among authors: gomez mora e.
J Antimicrob Chemother. 2018 Jul 1;73(7):1940-1948. doi: 10.1093/jac/dky106.
J Antimicrob Chemother. 2018.
PMID: 29635527
Free PMC article.
Clinical Trial.